O 1996 Kluwer Academic Publishers. Printed in the Netherlands. Original article

Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients [İleri evre küçük hücreli dişi akciger karsinomunda sisplatin-etoposid ile mitomisin-ifosfamid-sisplatin kombinasyonlarinin karşilaştirilmasi]

Çok G.
Göksel T.
Soyer S.
Atil H.
Güzelant A.
Aysan T.

January 2006

PubMed ID: 16924573Cisplatin-etoposide (CE) and mitomycin, ifosfamide and cisplatin (MIC) combinatio...

M. Viren
H. Joensuu
K. Mattson

September 2016

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cance

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

E. Baldini
C. Tibaldi
A. Chella
C. A. Angeletti
G. Silvano
A. Andrei
R. Algeri
CONTE, Pierfranco

January 1996

To evaluate the combination of vinorelbine, ifosfamide and cisplatin (VIP) in patients with advanced...

O 1995 Kluwcr Academic Publishers. Primed in the Netherlands. Original article

G. Martineui
R. Stahel
C. Ludwig

October 2016

Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A...

O 1996 Kluwer Academic Publishers. Printed in the Netherlands. Original article

A. Harstrick
H. -j. Schmoll

October 2016

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and ble...

Original article Randomized

C. P. Belani
J. S. Lee
M. A. Socinski
F. Robert
D. Waterhouse
K. Rowl
R. Ansari
R. Lilenbaum
R. B. Natale

January 2005

phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic no...

Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.

Ohnoshi, Taisuke
Hiraki, Shunkichi
Ueda, Nobuo
Fujii, Masafumi
Machida, Ken-ichi
Ueoka, Hiroshi
Kawahara, Shin
Kozuka, Akira
Kiura, Katsuyuki
Moritaka, Tomonori
Kodani, Tsuyoshi
Kamei, Haruhito
Kimura, Ikuro

October 1991

Twenty-seven previously untreated patients with unresectable non-small cell lung cancer were treated...

Original article

J. -l. Pujol
J. -l. Breton
R. Gervais
P. Rebattu
A. Depierre
J. -f. Morère
B. Milleron
D. Debieuvre
P. -j. Souquet
D. Moro-sibilot
R. Kessler
H. Janicot
D. Braun
D. Spaeth
X. Quantin
C. Clary

January 2004

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.

Crinò L.
Scagliotti GV
Ricci S
De Marinis F
Rinaldi M
Gridelli C
Ceribelli A
Marangolo M
Di Costanzo F
Sassi M
Barni S
Ravaioli A
Adamo V
Portalone L
Cruciani G
Masotti A
Ferrara G
Gozzelino F
Tonato M.
BIANCO, ROBERTO

January 1999

PURPOSE: To compare gemcitabine and cisplatin (GC) with mitomycin, ifosfamide, and cisplatin (MIC...

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer

Senan, Suresh
Brade, Anthony
Wang, Lu-Hua
Vansteenkiste, Johan
Dakhil, Shaker
Biesma, Bonne
Martinez Aguillo, Maite
Aerts, Joachim
Govindan, Ramaswamy
Rubio-Viqueira, Belén
Lewanski, Conrad
Gandara, David
Choy, Hak
Mok, Tony
Hossain, Anwar
Iscoe, Neill
Treat, Joseph
Koustenis, Andrew
San Antonio, Bélen
Chouaki, Nadia
Vokes, Everett

March 2016

The phase III PROCLAIM study evaluated overall survival (OS) of concurrent pemetrexed-cisplatin and ...

A. S. T. Planting
R. De Wit
G. Stoter
J. Verweij

September 2016

Phase II study of a closely spaced ifosfamide—cisplatin schedule with the addition of G-CSF in advan...

A Randomized Trial of Five Cisplatin-Containing Treatments in Patients With Metastatic Non-Small-Cell Lung Cancer: A Southwest Oncology Group Study

K. Weick
John Crowley
Ronald B. Natale
Ben Lin Hom
Saul Rivkin
Charles A. Coltman
Sarah A. Taylor
Robert B. Livingston

October 2016

Six hundred eighty assessable patients with measur-able stage III M1 non-small-cell lung cancer (NSC...

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group

Rudd, R. M.
Gower, N. H.
Spiro, S. G.
Eisen, T. G.
Harper, P. G.
Littler, J. A. H.
Hatton, M.
Johnson, P. W. M.
Martin, W. M. C.
Rankin, E. M.
James, L. E.
Gregory, W. M.
Qian, W.
Lee, S. M.

January 2005

NOTE: THE SYMBOLS/SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PL...

I. Teodorovic
G. Hoctin Boes
N. Colombo

October 2016

Purpose: Three previous mitomycin-cisplatin-based chemo-therapy trials conducted within the EORTC Gy...

W. Lange
R. Mertelsmann

October 2016

Background: We conducted a phase I—II trial to assess the feasibility and activity of a combination ...

Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients [İleri evre küçük hücreli dişi akciger karsinomunda sisplatin-etoposid ile mitomisin-ifosfamid-sisplatin kombinasyonlarinin karşilaştirilmasi]

Çok G.
Göksel T.
Soyer S.
Atil H.
Güzelant A.
Aysan T.

January 2006

PubMed ID: 16924573Cisplatin-etoposide (CE) and mitomycin, ifosfamide and cisplatin (MIC) combinatio...

M. Viren
H. Joensuu
K. Mattson

September 2016

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cance

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

E. Baldini
C. Tibaldi
A. Chella
C. A. Angeletti
G. Silvano
A. Andrei
R. Algeri
CONTE, Pierfranco

January 1996

To evaluate the combination of vinorelbine, ifosfamide and cisplatin (VIP) in patients with advanced...

O 1995 Kluwcr Academic Publishers. Primed in the Netherlands. Original article

G. Martineui
R. Stahel
C. Ludwig

October 2016

Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A...

O 1996 Kluwer Academic Publishers. Printed in the Netherlands. Original article

A. Harstrick
H. -j. Schmoll

October 2016

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and ble...

Original article Randomized

C. P. Belani
J. S. Lee
M. A. Socinski
F. Robert
D. Waterhouse
K. Rowl
R. Ansari
R. Lilenbaum
R. B. Natale

January 2005

phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic no...

Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.

Ohnoshi, Taisuke
Hiraki, Shunkichi
Ueda, Nobuo
Fujii, Masafumi
Machida, Ken-ichi
Ueoka, Hiroshi
Kawahara, Shin
Kozuka, Akira
Kiura, Katsuyuki
Moritaka, Tomonori
Kodani, Tsuyoshi
Kamei, Haruhito
Kimura, Ikuro

October 1991

Twenty-seven previously untreated patients with unresectable non-small cell lung cancer were treated...

Original article

J. -l. Pujol
J. -l. Breton
R. Gervais
P. Rebattu
A. Depierre
J. -f. Morère
B. Milleron
D. Debieuvre
P. -j. Souquet
D. Moro-sibilot
R. Kessler
H. Janicot
D. Braun
D. Spaeth
X. Quantin
C. Clary

January 2004

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung can...

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.

Crinò L.
Scagliotti GV
Ricci S
De Marinis F
Rinaldi M
Gridelli C
Ceribelli A
Marangolo M
Di Costanzo F
Sassi M
Barni S
Ravaioli A
Adamo V
Portalone L
Cruciani G
Masotti A
Ferrara G
Gozzelino F
Tonato M.
BIANCO, ROBERTO

January 1999

PURPOSE: To compare gemcitabine and cisplatin (GC) with mitomycin, ifosfamide, and cisplatin (MIC...

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer

Senan, Suresh
Brade, Anthony
Wang, Lu-Hua
Vansteenkiste, Johan
Dakhil, Shaker
Biesma, Bonne
Martinez Aguillo, Maite
Aerts, Joachim
Govindan, Ramaswamy
Rubio-Viqueira, Belén
Lewanski, Conrad
Gandara, David
Choy, Hak
Mok, Tony
Hossain, Anwar
Iscoe, Neill
Treat, Joseph
Koustenis, Andrew
San Antonio, Bélen
Chouaki, Nadia
Vokes, Everett

March 2016

The phase III PROCLAIM study evaluated overall survival (OS) of concurrent pemetrexed-cisplatin and ...

A. S. T. Planting
R. De Wit
G. Stoter
J. Verweij

September 2016

Phase II study of a closely spaced ifosfamide—cisplatin schedule with the addition of G-CSF in advan...

A Randomized Trial of Five Cisplatin-Containing Treatments in Patients With Metastatic Non-Small-Cell Lung Cancer: A Southwest Oncology Group Study

K. Weick
John Crowley
Ronald B. Natale
Ben Lin Hom
Saul Rivkin
Charles A. Coltman
Sarah A. Taylor
Robert B. Livingston

October 2016

Six hundred eighty assessable patients with measur-able stage III M1 non-small-cell lung cancer (NSC...

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group

Rudd, R. M.
Gower, N. H.
Spiro, S. G.
Eisen, T. G.
Harper, P. G.
Littler, J. A. H.
Hatton, M.
Johnson, P. W. M.
Martin, W. M. C.
Rankin, E. M.
James, L. E.
Gregory, W. M.
Qian, W.
Lee, S. M.

January 2005

NOTE: THE SYMBOLS/SPECIAL CHARACTERS IN THIS ABSTRACT CANNOT BE DISPLAYED CORRECTLY ON THIS PAGE. PL...

I. Teodorovic
G. Hoctin Boes
N. Colombo

October 2016

Purpose: Three previous mitomycin-cisplatin-based chemo-therapy trials conducted within the EORTC Gy...

W. Lange
R. Mertelsmann

October 2016

Background: We conducted a phase I—II trial to assess the feasibility and activity of a combination ...

Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients [İleri evre küçük hücreli dişi akciger karsinomunda sisplatin-etoposid ile mitomisin-ifosfamid-sisplatin kombinasyonlarinin karşilaştirilmasi]

Çok G.
Göksel T.
Soyer S.
Atil H.
Güzelant A.
Aysan T.

January 2006

PubMed ID: 16924573Cisplatin-etoposide (CE) and mitomycin, ifosfamide and cisplatin (MIC) combinatio...

M. Viren
H. Joensuu
K. Mattson

September 2016

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cance

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

E. Baldini
C. Tibaldi
A. Chella
C. A. Angeletti
G. Silvano
A. Andrei
R. Algeri
CONTE, Pierfranco

January 1996

To evaluate the combination of vinorelbine, ifosfamide and cisplatin (VIP) in patients with advanced...

O 1996 Kluwer Academic Publishers. Printed in the Netherlands. Original article

Abstract

Extracted data

O 1996 Kluwer Academic Publishers. Printed in the Netherlands. Original article

Abstract

Extracted data

Related items

Related items